Latest News about General
Recent news which mentions General
Agios Pharmaceuticals' Rare Blood Disorder Drug Misses Primary Goal In Pediatric Study, Stock Slides
August 01, 2024
From Benzinga
LabCorp's Stock Soars After Q2 Performance, Analyst Highlights Strong Position In Healthcare Sector
August 01, 2024
From Benzinga
Regeneron Pharmaceuticals' Q2 Earnings Exceed Estimates, Driven By Its Top-Selling Eczema And Eye Drugs
August 01, 2024
From Benzinga
Why Is EV Charging Provider EVgo Stock Sliding Today?
August 01, 2024
From Benzinga
Cigna's Q2 Profit Beats Analyst Estimates As Evernorth Health Services Growth Builds Momentum, Reiterates Annual Outlook
August 01, 2024
From Benzinga
Biogen Q2 Earnings: Beats Consensus, Lifts 2024 Profit Forecast As New Drug Launches Expected To Offset Decline In Multiple Sclerosis Med Sales
August 01, 2024
From Benzinga
Meta Joins The AI Spending Spree But Shields Itself With Strong Ad Revenue And Earnings Beat
August 01, 2024
From Benzinga
Shake Shack Q2 Earnings: Revenue And Profit Beat, Clocks High Operating Margin And Strong System-wide Sales Growth
August 01, 2024
From Benzinga
From Benzinga
Moderna Stock Sinks On Lowered 2024 Outlook, Cites Low European Sales, Competitive RSV Vaccine Market
August 01, 2024
From Benzinga
GM's Impressive Streak Overshadowed By EV Transition Challenges
August 01, 2024
From Benzinga
Market Clubhouse Morning Memo - August 1st, 2024 (Trade Strategy For SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META And TSLA)
August 01, 2024
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.